Total Payments
$470.82
2024 Payments
$98.28
Companies
3
Transactions
4
Medicare Patients
479
Medicare Billing
$40,483

Payment Breakdown by Category

Food & Beverage$470.82 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $470.82 4 100.0%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $220.82 2 $0 (2024)
Lilly USA, LLC $125.00 1 $0 (2023)
Novo Nordisk Inc $125.00 1 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $98.28 1 AstraZeneca Pharmaceuticals LP ($98.28)
2023 $247.54 2 Lilly USA, LLC ($125.00)
2022 $125.00 1 Novo Nordisk Inc ($125.00)

All Payment Transactions

4 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
02/13/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $98.28 General
Category: Respiratory
04/13/2023 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage Cash or cash equivalent $125.00 General
Category: Diabetes
02/15/2023 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $122.54 General
Category: Cardiovascular and Metabolism
06/01/2022 Novo Nordisk Inc Ozempic (Drug) Food and Beverage In-kind items and services $125.00 General
Category: Diabetes

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 10 381 447 $98,971 $32,891
2022 3 98 104 $23,175 $7,593
Total Patients
479
Total Services
551
Medicare Billing
$40,483
Procedure Codes
13

All Medicare Procedures & Services

13 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 103 144 $44,085 $12,715 28.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 85 90 $18,670 $4,990 26.7%
90677 Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use Office 2023 14 14 $4,480 $3,946 88.1%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 27 27 $7,668 $3,325 43.4%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 20 20 $8,631 $2,620 30.4%
90662 Influenza vaccine split virus, preservative free Office 2023 37 37 $4,758 $2,610 54.9%
G0008 Administration of influenza virus vaccine Office 2023 48 48 $2,640 $1,384 52.4%
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional Office 2023 22 42 $5,814 $668.13 11.5%
G0009 Administration of pneumococcal vaccine Office 2023 14 14 $740.00 $412.30 55.7%
90686 Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage Office 2023 11 11 $1,485 $219.00 14.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 49 55 $16,225 $5,101 31.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 30 30 $6,000 $1,954 32.6%
G0008 Administration of influenza virus vaccine Office 2022 19 19 $950.00 $537.51 56.6%

About Dr. Olivia Fladmark, M.D

Dr. Olivia Fladmark, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Sunbury, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/17/2019. The National Provider Identifier (NPI) number assigned to this provider is 1275196008.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Olivia Fladmark, M.D has received a total of $470.82 in payments from pharmaceutical and medical device companies, with $98.28 received in 2024. These payments were reported across 4 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($470.82).

As a Medicare-enrolled provider, Fladmark has provided services to 479 Medicare beneficiaries, totaling 551 services with total Medicare billing of $40,483. Data is available for 2 years (2022–2023), covering 13 distinct procedure/service records.

Practice Information

Products in Payments

  • MOUNJARO (Drug) $125.00
  • Ozempic (Drug) $125.00
  • FARXIGA (Drug) $122.54
  • AIRSUPRA (Drug) $98.28

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Sunbury